CHERIE REVERE: Open Payments
NPI 1356396659 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 30 payments from 14 companies in 2025. Trend: 2023 $1,032 · 2024 $256 · 2025 $777
Food & beverage: $678Education: $99
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 6 | $164 |
| Medtronic, Inc. | 2 | $99 |
| Boston Scientific Corporation | 3 | $72 |
| PFIZER INC. | 3 | $57 |
| Baxter Healthcare | 1 | $56 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Philips North America LLC | 2 | $50 |
| GE HEALTHCARE | 2 | $47 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| BridgeBio Pharma, Inc. | 2 | $40 |
Products named: AMVUTTRA, VYNDAQEL, Hillrom - Carnation Ambulatory Monitor, CDS - MCT/CEM Monitoring, Attruby, JARDIANCE, Ambulatory Monitoring & Diagnostics Undivided, AREXVY.
Industry payments across AL — which companies pay providers there.
